These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 19162337)

  • 21. The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases.
    Kuwabara T; Ishikawa F; Kondo M; Kakiuchi T
    Mediators Inflamm; 2017; 2017():3908061. PubMed ID: 28316374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophils, interleukin-17A and lung disease.
    Lindén A; Laan M; Anderson GP
    Eur Respir J; 2005 Jan; 25(1):159-72. PubMed ID: 15640338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes.
    Shin JH; Shin DW; Noh M
    Biochem Pharmacol; 2009 Jun; 77(12):1835-44. PubMed ID: 19428338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signalling, inflammation and arthritis: crossed signals: the role of interleukin (IL)-12, -17, -23 and -27 in autoimmunity.
    Paunovic V; Carroll HP; Vandenbroeck K; Gadina M
    Rheumatology (Oxford); 2008 Jun; 47(6):771-6. PubMed ID: 18238793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma.
    Saitoh T; Kusunoki T; Yao T; Kawano K; Kojima Y; Miyahara K; Onoda J; Yokoi H; Ikeda K
    Int Arch Allergy Immunol; 2010; 151(1):8-16. PubMed ID: 19672092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis.
    Siegemund S; Schütze N; Schulz S; Wolk K; Nasilowska K; Straubinger RK; Sabat R; Alber G
    Int Immunol; 2009 May; 21(5):555-65. PubMed ID: 19297659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine signal regulation and autoimmune disorders.
    Nishimoto N
    Autoimmunity; 2005 Aug; 38(5):359-67. PubMed ID: 16227151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
    Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
    Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic targets along the Th17 pathway.
    Ouyang W; Filvaroff E; Hu Y; Grogan J
    Eur J Immunol; 2009 Mar; 39(3):670-5. PubMed ID: 19283720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-25: a key requirement for the regulation of type-2 immunity.
    Barlow JL; McKenzie AN
    Biofactors; 2009; 35(2):178-82. PubMed ID: 19449446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
    Brereton CF; Sutton CE; Lalor SJ; Lavelle EC; Mills KH
    J Immunol; 2009 Aug; 183(3):1715-23. PubMed ID: 19570828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and signalling in the IL-17 receptor family.
    Gaffen SL
    Nat Rev Immunol; 2009 Aug; 9(8):556-67. PubMed ID: 19575028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
    Monteleone G; Pallone F; Macdonald TT
    Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-17 in Chronic Inflammation: From Discovery to Targeting.
    Beringer A; Noack M; Miossec P
    Trends Mol Med; 2016 Mar; 22(3):230-241. PubMed ID: 26837266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 5 in the link between the innate and acquired immune response.
    Takatsu K; Kouro T; Nagai Y
    Adv Immunol; 2009; 101():191-236. PubMed ID: 19231596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
    Martin-Orozco N; Dong C
    Curr Opin Investig Drugs; 2009 Jun; 10(6):543-9. PubMed ID: 19513943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation.
    Zhang X; Jin J; Tang Y; Speer D; Sujkowska D; Markovic-Plese S
    J Immunol; 2009 Mar; 182(6):3928-36. PubMed ID: 19265172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excessive interleukin-1 signaling determines the development of Th1 and Th17 responses in chronic inflammation.
    Joosten LA
    Arthritis Rheum; 2010 Feb; 62(2):320-2. PubMed ID: 20112403
    [No Abstract]   [Full Text] [Related]  

  • 39. Chosen IL-17 family proteins in neutrophils of patients with oral inflammation.
    Garley M; Jablonska E
    Adv Med Sci; 2008; 53(2):326-30. PubMed ID: 19095584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma/delta T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis.
    Ito Y; Usui T; Kobayashi S; Iguchi-Hashimoto M; Ito H; Yoshitomi H; Nakamura T; Shimizu M; Kawabata D; Yukawa N; Hashimoto M; Sakaguchi N; Sakaguchi S; Yoshifuji H; Nojima T; Ohmura K; Fujii T; Mimori T
    Arthritis Rheum; 2009 Aug; 60(8):2294-303. PubMed ID: 19644886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.